NO952130D0 - Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalen - Google Patents

Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalen

Info

Publication number
NO952130D0
NO952130D0 NO952130A NO952130A NO952130D0 NO 952130 D0 NO952130 D0 NO 952130D0 NO 952130 A NO952130 A NO 952130A NO 952130 A NO952130 A NO 952130A NO 952130 D0 NO952130 D0 NO 952130D0
Authority
NO
Norway
Prior art keywords
benzodiazepine
thieno
treatment
gastrointestinal conditions
gastrointestinal
Prior art date
Application number
NO952130A
Other languages
English (en)
Other versions
NO952130L (no
NO306977B1 (no
Inventor
Beverly Greenwood
David Lloyd Garver Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952130D0 publication Critical patent/NO952130D0/no
Publication of NO952130L publication Critical patent/NO952130L/no
Publication of NO306977B1 publication Critical patent/NO306977B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO952130A 1994-06-03 1995-05-30 Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen NO306977B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/253,658 US5457101A (en) 1994-06-03 1994-06-03 Thieno[1,5]benzoidiazepine use

Publications (3)

Publication Number Publication Date
NO952130D0 true NO952130D0 (no) 1995-05-30
NO952130L NO952130L (no) 1995-12-04
NO306977B1 NO306977B1 (no) 2000-01-24

Family

ID=22961179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952130A NO306977B1 (no) 1994-06-03 1995-05-30 Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen

Country Status (14)

Country Link
US (1) US5457101A (no)
EP (1) EP0685233B1 (no)
JP (1) JPH07330608A (no)
KR (1) KR960000229A (no)
CN (1) CN1119101A (no)
AU (1) AU684924B2 (no)
CA (1) CA2150517A1 (no)
DE (1) DE69528109D1 (no)
HU (1) HUT71598A (no)
IL (1) IL113912A (no)
NO (1) NO306977B1 (no)
NZ (1) NZ272231A (no)
TW (1) TW372872B (no)
ZA (1) ZA954358B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
BR9612552A (pt) * 1996-03-11 1999-07-20 Lilly Co Eli Processo para tratamento de autismo
CN1213966A (zh) * 1996-03-11 1999-04-14 伊莱利利公司 治疗两极紊乱的方法
PL329221A1 (en) * 1996-03-25 1999-03-15 Lilly Co Eli Method of relieving hemicrania pains
AU721338B2 (en) * 1996-03-25 2000-06-29 Eli Lilly And Company Method for treating pain
AU725556B2 (en) * 1996-03-25 2000-10-12 Eli Lilly And Company Method for treating pain
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
WO1998046596A1 (en) * 1997-04-15 1998-10-22 Eli Lilly And Company Method for providing neuro-protective effects
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen
JP2002530341A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0207091D0 (en) * 2002-03-26 2002-05-08 Ml Lab Plc Method of treatment
US7407788B2 (en) * 2002-11-21 2008-08-05 Danisco A/S, Genencor Division BGL7 beta-glucosidase and nucleic acids encoding the same
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
DE602005027308D1 (de) * 2004-01-27 2011-05-19 Synthon Bv Stabile salze von olanzapin
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2597716A1 (en) * 2005-02-15 2006-08-24 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
CL2007002807A1 (es) * 2006-09-29 2008-04-11 Synthon Bv Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
WO2012051502A1 (en) 2010-10-14 2012-04-19 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds
US20210355138A1 (en) * 2016-08-11 2021-11-18 Eli Lilly And Company Aminothiazinies and their use as bace1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
PT582368E (pt) * 1992-05-29 2001-05-31 Lilly Co Eli Derivados de tienobenzodiazepina para o tratamento de doencas de cns
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
HUT75522A (en) * 1994-03-11 1997-05-28 Lilly Co Eli Indole-, pyrido-indole-, indolo-quinoline- and benzo-pyrido-indole-derivatives, method for treating 5ht2b receptor related conditions, pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1119101A (zh) 1996-03-27
KR960000229A (ko) 1996-01-25
US5457101A (en) 1995-10-10
IL113912A0 (en) 1995-08-31
DE69528109D1 (de) 2002-10-17
NO952130L (no) 1995-12-04
HU9501600D0 (en) 1995-07-28
EP0685233A2 (en) 1995-12-06
AU684924B2 (en) 1998-01-08
TW372872B (en) 1999-11-01
ZA954358B (en) 1996-11-29
IL113912A (en) 1999-04-11
NZ272231A (en) 2001-05-25
JPH07330608A (ja) 1995-12-19
CA2150517A1 (en) 1995-12-04
EP0685233A3 (en) 1996-04-03
EP0685233B1 (en) 2002-09-11
NO306977B1 (no) 2000-01-24
HUT71598A (en) 1996-01-29
AU2042495A (en) 1995-12-14

Similar Documents

Publication Publication Date Title
NO952130L (no) Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalen
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
FI960548A0 (fi) Foerfarande foer behandling av terminals foerbindelse med satellitkommunikationssystem
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO944871D0 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
FI980387A0 (fi) Foerfarande foer att foerhindra bildning av utfaellningar i svartlutsindunstare
NO972402D0 (no) Fremgangsmåte for fremstilling av bærere
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20000933L (no) Fremgangsmõte for fremstilling av polymer
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO982562D0 (no) Sammensetning for behandling av smerte
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
ID18263A (id) Proses pembuatan polietilena tereftalat
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
NO985558D0 (no) Ny forbedret formulering for behandling av tromboembolisme
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO984190D0 (no) Fremgangsmåte for behandling av insomnia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002